Institute of Molecular Virology, Ulm University Medical Center, Ulm, Baden-Wuerttemberg, Germany.
Florida Research and Innovation Center, Cleveland Clinic, Port St Lucie, Florida, USA.
Autophagy. 2024 May;20(5):994-1014. doi: 10.1080/15548627.2023.2281128. Epub 2023 Nov 17.
Macroautophagy/autophagy is a tightly regulated cellular process integral to homeostasis and innate immunity. As such, dysregulation of autophagy is associated with cancer, neurodegenerative disorders, and infectious diseases. While numerous factors that promote autophagy have been characterized, the key mechanisms that prevent excessive autophagy are less well understood. Here, we identify CSNK2/CK2 (casein kinase 2) as a negative regulator of autophagy. Pharmacological inhibition of CSNK2 activity or siRNA-mediated depletion of CSNK2 increased basal autophagic flux in cell lines and primary human lung cells. , ectopic expression of CSNK2 reduced autophagic flux. Mechanistically, CSNK2 interacted with the FLN (filamin)-NHL domain-containing tripartite motif (TRIM) family members TRIM2, TRIM3 and TRIM71. Our data show that recruitment of CSNK2 to the C-terminal NHL domain of TRIM3 lead to its robust phosphorylation at serine 661 by CSNK2. A phosphorylation-defective mutant of TRIM3 was unable to reduce autophagosome numbers indicating that phosphorylation by CSNK2 is required for TRIM-mediated autophagy inhibition. All three TRIMs facilitated inactivation of the ULK1-BECN1 autophagy initiation complex by facilitating ULK1 serine 757 phosphorylation. Inhibition of CSNK2 promoted autophagy upon influenza A virus (IAV) and measles virus (MeV) infection. In line with this, targeting of CSNK2 or depletion of TRIM2, TRIM3 or TRIM71 enhanced autophagy-dependent restriction of IAV, MeV and human immunodeficiency virus 1 (HIV-1). Thus, our results identify the CSNK2-TRIM2, -TRIM3, -TRIM71 axis as a key regulatory pathway that limits autophagy. Targeting this axis may allow for therapeutic induction of autophagy against viral infections and in diseases associated with dysregulated autophagy. ATG5: autophagy related 5; BafA1: bafilomycin A; BECN1: beclin 1; CCD: coiled-coil domain; CSNK2/CK2: casein kinase 2; CSNK2A1: casein kinase 2 alpha 1; CSNK2A2: casein kinase 2 alpha 2; CSNK2B: casein kinase 2 beta; FLN: filamin; HeLa GL: HeLa cells stably expressing eGFP-LC3B; HIV-1: human immunodeficiency virus 1; IAV: influenza A virus; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3; MeV: measles virus; MTOR: mechanistic target of rapamycin kinase; RING: really interesting new gene; SQSTM1/p62: sequestosome 1; TRIM: tripartite motif; ULK1: unc-51 like autophagy activating kinase 1.
自噬是一种受严格调控的细胞过程,对维持内环境稳定和先天免疫至关重要。因此,自噬的失调与癌症、神经退行性疾病和传染病有关。虽然已经有许多促进自噬的因素被描述出来,但阻止自噬过度的关键机制还不太清楚。在这里,我们发现 CSNK2/CK2(酪蛋白激酶 2)是自噬的负调控因子。CSNK2 活性的药理学抑制或 siRNA 介导的 CSNK2 耗竭增加了细胞系和原代人肺细胞中的基础自噬通量。相反,CSNK2 的异位表达降低了自噬通量。在机制上,CSNK2 与 FLN(细丝蛋白)-NHL 结构域包含的三聚体基序(TRIM)家族成员 TRIM2、TRIM3 和 TRIM71 相互作用。我们的数据表明,CSNK2 募集到 TRIM3 的 C 端 NHL 结构域导致 CSNK2 对其丝氨酸 661 的强烈磷酸化。TRIM3 的磷酸化缺陷突变体不能减少自噬体的数量,表明 CSNK2 的磷酸化是 TRIM 介导的自噬抑制所必需的。所有三种 TRIM 都通过促进 ULK1 丝氨酸 757 的磷酸化来促进 ULK1-BECN1 自噬起始复合物的失活。流感 A 病毒(IAV)和麻疹病毒(MeV)感染后,CSNK2 的抑制促进了自噬。与此一致的是,靶向 CSNK2 或耗尽 TRIM2、TRIM3 或 TRIM71 增强了 IAV、MeV 和人类免疫缺陷病毒 1(HIV-1)的自噬依赖性限制。因此,我们的结果确定了 CSNK2-TRIM2、-TRIM3、-TRIM71 轴作为限制自噬的关键调节途径。靶向该轴可能允许针对病毒感染和与自噬失调相关的疾病进行治疗性诱导自噬。ATG5:自噬相关 5;BafA1:巴佛霉素 A;BECN1:beclin 1;CCD:卷曲螺旋结构域;CSNK2/CK2:酪蛋白激酶 2;CSNK2A1:酪蛋白激酶 2 alpha 1;CSNK2A2:酪蛋白激酶 2 alpha 2;CSNK2B:酪蛋白激酶 2 beta;FLN:细丝蛋白;HeLa GL:稳定表达 eGFP-LC3B 的 HeLa 细胞;HIV-1:人类免疫缺陷病毒 1;IAV:流感 A 病毒;MAP1LC3B/LC3B:微管相关蛋白 1 轻链 3;MeV:麻疹病毒;MTOR:雷帕霉素靶蛋白激酶;RING:真正有趣的新基因;SQSTM1/p62:自噬相关蛋白 1;TRIM:三聚体基序;ULK1:UNC-51 样自噬激活激酶 1。